Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Human prion protein sequence elements impede cross-species chronic wasting disease transmission
Timothy D. Kurt, … , Qingzhong Kong, Christina J. Sigurdson
Timothy D. Kurt, … , Qingzhong Kong, Christina J. Sigurdson
Published February 23, 2015
Citation Information: J Clin Invest. 2015;125(4):1485-1496. https://doi.org/10.1172/JCI79408.
View: Text | PDF | Erratum
Research Article Infectious disease Neuroscience

Human prion protein sequence elements impede cross-species chronic wasting disease transmission

  • Text
  • PDF
Abstract

Chronic wasting disease (CWD) is a fatal prion disease of North American deer and elk and poses an unclear risk for transmission to humans. Human exposure to CWD occurs through hunting activities and consumption of venison from prion-infected animals. Although the amino acid residues of the prion protein (PrP) that prevent or permit human CWD infection are unknown, NMR-based structural studies suggest that the β2-α2 loop (residues 165–175) may impact species barriers. Here we sought to define PrP sequence determinants that affect CWD transmission to humans. We engineered transgenic mice that express human PrP with four amino acid substitutions that result in expression of PrP with a β2-α2 loop (residues 165–175) that exactly matches that of elk PrP. Compared with transgenic mice expressing unaltered human PrP, mice expressing the human-elk chimeric PrP were highly susceptible to elk and deer CWD prions but were concurrently less susceptible to human Creutzfeldt-Jakob disease prions. A systematic in vitro survey of amino acid differences between humans and cervids identified two additional residues that impacted CWD conversion of human PrP. This work identifies amino acids that constitute a substantial structural barrier for CWD transmission to humans and helps illuminate the molecular requirements for cross-species prion transmission.

Authors

Timothy D. Kurt, Lin Jiang, Natalia Fernández-Borges, Cyrus Bett, Jun Liu, Tom Yang, Terry R. Spraker, Joaquín Castilla, David Eisenberg, Qingzhong Kong, Christina J. Sigurdson

×

Figure 1

Mice expressing a human-elk chimeric PrPC are infected by CWD prions.

Options: View larger image (or click on image) Download as PowerPoint
Mice expressing a human-elk chimeric PrPC are infected by CWD prions.
(A...
(A) Human PrPC sequence with elk residue differences shown below. The human residue Q223 is also present in mule deer, but is E223 in elk. Amino acid substitutions present in the Tg(HuPrPelk166–174) mice are in red. (B) Neurologic signs in CWD-inoculated Tg(HuPrPelk166–174) mice included hind limb clasp (arrow) typical of prion disease, whereas the hind limb splay of Tg(HuPrP) mice was normal. (C) Kaplan-Meier survival curves of CWD-inoculated Tg(HuPrPelk166–174) mice reveal a significant decrease in the incubation period on second passage. One mouse died with intercurrent disease at 109 dpi. No Tg(HuPrP) mice developed clinical signs of infection after CWD inoculation. Prion infection status was confirmed by biochemical and histologic assays. P1 and P2, passages 1 and 2. (D) Diffuse PrPSc deposition, spongiform degeneration (arrowheads) (H&E), and astrogliosis (GFAP) localize to the thalamus of deer or elk CWD–inoculated Tg(HuPrPelk166–174) mice, but do not occur in elk CWD–inoculated Tg(HuPrP) mice. Scale bar: 50 μm. (E) The CJD-inoculated Tg(HuPrP) mice manifested neurologic signs, including a stiff tail (arrow), by 173 dpi. (F) Tg(HuPrP) mice inoculated with human sCJD prions developed terminal disease by 186 dpi, whereas Tg(HuPrPelk166–174) animals developed terminal disease between 260 and 290 dpi. **P < 0.01; ***P < 0.001; log-rank (Mantel-Cox) test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts